IRVINE, Calif.–(BUSINESS WIRE)–NeuroOptics Automated Pupillarymetry and Neurological Pupillary Index™ (NPi®) Unaffected by Clinical Addiction in Emergency Room Patients A newly published clinical study shows that it can be used to rapidly screen for To brain injury or nerve injury regardless of drunkenness.
This press release features multimedia. Read the full release here: https://www.businesswire.com/news/home/20230110005401/en/
NeurOptics’ automatic pupillometer has emerged as a key technology that provides a reliable measurement of pupil size and reactivity expressed as the Neurological Pupil Index (NPi). (Image: Business Wire)
Research published in American Journal of Emergency Medicine, conducted at the Emergency Department of the University of Pennsylvania Hospital and the Penn Presbyterian Medical Center (PPMC) in Philadelphia, enrolled 119 patients with confirmed clinical intoxication with ethanol, opioids, or other drugs of abuse. This study examines the effects of various addictive drug classes on pupillometric measures and the potential benefits of pupillometric measures as a tool for rapid assessment of clinically intoxicated patients in the emergency department (ED). was evaluated.
The results showed that clinical intoxication affected pupil size and other individual measures of pupillary light reflex, but no statistical differences in NPi were observed between intoxicated and control subjects. NPi remained immune to clinical addiction and thus may be used for evaluation in ED patients without the risk of confounding by major toxicants of abuse.
Benjamin S. Abella, M.D., Ph.D., Principal Investigator, Department of Emergency Medicine, University of Pennsylvania Hospital. “This is the first study of addicted patients in the emergency department, and we believe that the NPi is a reliable tool for assessing and triaging patients, providing useful insights into neurological function irrespective of addiction, including those caused by opioids.” It clearly shows that it is an indicator.”
NeurOptics’ automatic pupillometer has emerged as a key technology that provides a reliable measurement of pupil size and reactivity expressed as the Neurological Pupil Index (NPi). NPi values range from 0 to 4.9, with scores below 3 considered abnormal. The NPi Pupillometer is the only monitoring device that reliably and accurately confirms whether the pupil is responding normally or abnormally during the triage of patients with mental status disorders (AMS) in the ED, and it and neurological examination of pediatric patients. Post-cardiac arrest, including traumatic brain injury, stroke, seizure, or other neurological event.
About NeuroOptics
Headquartered in Irvine, Calif., NeuroOptics is the world leader in pupillography. Driven by a passion to help clinicians improve patient outcomes, NeuroOptics develops and markets innovative technologies for use in critical care, neurology, neurosurgery, emergency medicine, and research. doing. His NPi Pupillometer from NeurOptics has been included in over 100 clinical studies, has been adopted by over 600 of his hospitals in the United States, and is used in over 30 countries worldwide. For more information, please visit www.NeurOptics.com. Facebook, LinkedIn, and twitter.
View source version at businesswire.com: https://www.businesswire.com/news/home/20230110005401/en/
